2/10/2020 1:54 PM
One biotech in focus this afternoon is Adverum Biotechnologies Inc (NASDAQ:ADVM), the equity surging near the top of the Nasdaq Composite (IXIC) after revealing an upbeat, early stage trial data for i...
9/12/2019 9:43 AM
The shares of Adverum Biotechnologies Inc (NASDAQ:ADVM) are taking a serious nosedive today, down 32.8% at $8.07, after data from an early stage trial of the company's wet age-related macular degener...
11/2/2018 2:37 PM
The Dow has explored a 500-point trading range on both sides of breakeven, as Wall Street digests the latest trade developments and a negative earnings reaction for Apple (AAPL). Among other stocks m...